Atlas Trials

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Clinical trial NCT04304820 · RECRUITING

Trial details

NCT number
NCT04304820
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Aplastic Anemia
Start date
2020-05-07
Primary completion
2024-12-18
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.